Brind.

A product involving T. Hasegawa and Mintel successfully met FDA natural flavour guidelines based on market research.

1 report, 1 independent Updated May 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA T. Hasegawa Mintel

Keep exploring

The entities involved

FDA
- The FDA reviews a voluntary recall of a blood pressure drug.02:00
- CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy Casgevy for sickle cell disease.Mon 23:09
T. Hasegawa
Japanese flavours and fragrances company

Nothing else this week.
Mintel
UK-based global market research firm
- Mintel tracks spending habits of Spanish adults and establishes a partnership with Pilkington.Fri 20:41

Related events

FDA approval is the goal for product candidates from Daré Bioscience, Inc.Jun 7

Coverage

Newest first; wire copies grouped

May 27foodbev.com